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In clinical practice, kidney injury is detected when serum creatinine concentrations increase over a short period of time, 
with or without oliguria. To assess renal function in neonates is used determination of glomerular filtration rate (GFR) after 
creatinine. But creatinine concentration is not a decisive marker. Changes in serum creatinine may be influenced by other factors, 
which are not directly related to kidney damage, such as age, sex, body mass and nutritional status. Serum creatinine is a poor 
marker of kidney dysfunction because GFR become increased only when the kidneys have lost 50% of their functional capacity. 
Therefore, there are objective difficulties for a correct evaluation of renal function after serum creatinine. Serum cystatin C is 
recognized as the most accurate endogenous marker of GFR. Cystatin C is a 13-kd endogenous cysteine proteinase inhibitor and is 
produced by all nucleated cells. Cystatin C is freely filtered by the glomerulus, reabsorbed, and catabolized, but not secreted by 
the tubules. Cystatin C, determined in serum, is an endogenous marker of kidney function, detected earlier than creatinine. Serum 
cystatin C concentrations are independent of age, sex, race, and body mass and hydration level. Serum concentrations of cystatin 
C may be used to detect renal dysfunction in critically ill patients with kidney injury 24–48 h earlier than creatinine measurements 
The purpose of the work is to study the diagnostic value of determination of cystatin C in serum in full-term infants with 
disturbance of kidney function due to severe asphyxia. 
Materials and methods. The study involved 15 children with kidney injury due to severe asphyxia. Comparison group 
consisted of 10 infants without asphyxia at birth. The cystatin C level in serum was determined on 1-2, 7-8 and 25-30 days of life 
by ELISA. GFR calculated after cystatin C using A. Grubb formula. 
Results. The absolute GFR values in healthy infants are low and within 1 month of life levels do not exceed 35-46 
ml/min. These GFR levels are physiological and don’t represent a violation of the filtration function in contrast with older children 
and adults. In children with renal disturbance due to severe asphyxia are noted statistical decreases in GFR at 1-2 days of life. At 
the end of the early neonatal period were marked the lowest levels of GFR. These levels were twice lower than in healthy 
newborns. Further, GFR recovered to level at birth, but its index still remained rather low (p <0,05) relatively healthy newborns. 
Conclusion. Cystatin C is early and sensitive indicator of renal dysfunction because it content in serum significantly increased 
already at 1-2 days after birth. During the neonatal period, GFR, calculated by cystatin C, characterizes the filtration value in 
infants with kidney disturbance due to asphyxia. 
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